M&A Healthcare Advisors (“MAHA”) is pleased to present Project Gamma (the “Companies”), a portfolio of ACR accredited, diagnostic imaging centers. The Companies, through their 4 centers, have been providing advanced medical imaging services in South Florida for over 30 years. Utilizing state-of-the-art technology, the Companies offer a comprehensive range of imaging modalities, including biopsy, computed tomography, magnetic resonance imaging, 3D mammography, nuclear medicine, PET/CT scans, ultrasound, and more.
From 2022 to 2024, the Companies have provided services to an average of 39,000 patients annually and are in-network with over 35 insurance companies. With over 50 employees and a 9K+ physician referral base, the Companies are well positioned for continued growth.
Financial Overview
2023 | 2024 | |
Revenue | 8.2M | 8.8M |
Gross Profit | 5.1M | 5.7M |
Adjusted EBITDA | .3M | 1.3M |
EBITDA Margin | 3% | 15% |
Our clients, the ownership group, have retained MAHA to explore a transaction. Management and ownership are open to evaluating their roles and responsibilities post-transaction. If you would like to learn more about Project Gamma, please sign our NDA via the link below.